CytoMed Therapeutics Limi... (GDTC)
NASDAQ: GDTC
· Real-Time Price · USD
2.00
0.03 (1.52%)
At close: Sep 26, 2025, 3:57 PM
1.95
-2.50%
After-hours: Sep 26, 2025, 04:00 PM EDT
CytoMed Therapeutics Revenue
CytoMed Therapeutics reported an annual revenue of $52.01K, reflecting a -82.1% growth. For the quarter ending December 31, 2024, CytoMed Therapeutics generated $52.41K in revenue.
Revenue (ttm)
52.01K
Revenue Growth
-82.1%
Price / Sales Ratio
754.46
Revenue / Employee
1.21K
Employees
43
Market Cap
23.47M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 52.01K | -82.10% |
| Dec 31, 2023 | 290.56K | +7.48% |
| Dec 31, 2022 | 270.34K | +221.15% |
| Dec 31, 2021 | 84.18K | +87.38% |
| Dec 31, 2020 | 44.92K | +Infinity% |
| Dec 31, 2019 | 0 | n/a |